Dombeck Carrie, Swezey Teresa, Kehoe Lindsay, Kinchen Kraig, Roe Matthew, Stewart Mark, Corneli Amy
Clinical Trials Transformation Initiative, Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC, USA.
Department of Population Health Sciences, Duke University School of Medicine, Durham, NC, USA.
J Clin Transl Sci. 2024 Oct 17;8(1):202. doi: 10.1017/cts.2024.647. eCollection 2024.
Researchers and policymakers recognize that leveraging data routinely collected in clinical practice can support improved research and patient care. Embedding elements of clinical trials, such as patient identification and trial data acquisition, into clinical practice can enable research access and increase efficiencies by reducing duplication of trial and care activities. Yet, cultural, administrative, and data barriers exist. The Clinical Trials Transformation Initiative (CTTI) developed evidenced-based, multi-partner recommendations to facilitate embedding interventional, randomized trials into clinical practice.
We conducted in-depth interviews (IDIs) with trial designers and implementers to describe their motivations for embedding interventional, randomized trials into clinical practice. Additionally, we aimed to identify barriers and potential solutions to implementing such trials. Interviews were audio-recorded and analyzed using applied thematic analysis.
We conducted 16 IDIs with 18 trial designers and implementers. Motivations for embedding trials into clinical practice included the desire to implement a learning health system and evaluate trials in real-world settings. Barriers to trial implementation focused on limited staff time and availability, the lack of buy-in, and difficulties using electronic health record data. Solutions included minimizing healthcare settings and patient burden, having a sufficient data and research infrastructure in place, and creating a culture change.
The results informed CTTI recommendations to facilitate the design and operation of embedded trials. These recommendations emphasize areas where sponsors and investigators can rethink the design and conduct of clinical trials to ultimately realize an aligned system of research and care.
研究人员和政策制定者认识到,利用临床实践中常规收集的数据有助于改进研究和患者护理。将临床试验的要素(如患者识别和试验数据采集)融入临床实践,可以实现研究准入,并通过减少试验和护理活动的重复来提高效率。然而,文化、行政和数据方面的障碍依然存在。临床试验转型倡议(CTTI)制定了基于证据的多伙伴建议,以促进将干预性随机试验融入临床实践。
我们对试验设计者和实施者进行了深入访谈(IDI),以描述他们将干预性随机试验融入临床实践的动机。此外,我们旨在识别实施此类试验的障碍和潜在解决方案。访谈进行了录音,并使用应用主题分析法进行分析。
我们对18名试验设计者和实施者进行了16次深入访谈。将试验融入临床实践的动机包括实施学习型健康系统的愿望以及在现实环境中评估试验。试验实施的障碍集中在工作人员时间有限和可用性不足、缺乏支持以及使用电子健康记录数据存在困难。解决方案包括尽量减少医疗机构和患者负担、建立足够的数据和研究基础设施以及营造文化变革。
研究结果为CTTI促进嵌入式试验设计和运营的建议提供了依据。这些建议强调了申办者和研究者可以重新思考临床试验设计和实施的领域,以最终实现研究与护理的协同系统。